Ke Lawrence

Prevalence of anthelmintic resistance on 62 beef cattle farms in the North Island of New Zealand

Abstract AIM: To establish the prevalence of anthelmintic resistance in parasitic nematodes on a random sample of beef cattle herds in the North Island of New Zealand. METHODS: A cross-sectional prevalence study was conducted using a standardised faecal nematode egg count (FEC) reduction (FECR) test (FECRT) for ivermectin, levamisole and albendazole on 60 calves on each of 62 farms in the North Island chosen at random from farms that conformed with the selection criteria. Resistance to an anthelmintic was inferred when there was <95% reduction in FEC 7-10 days after treatment. Larval cultures were performed for all control groups and for treated groups for which resistance was evident. RESULTS: Of the farms that completed the FECRT, 4/61 (7%) showed ≥95% reduction in FEC for all anthelmintics tested. Resistance to ivermectin was evident on 56/61 (92%) farms, to albendazole on 47/62 (76%) farms, and to both ivermectin and albendazole on 45/61 (74%) farms. Resistance to levamisole was evident on only 4/62 (6%) farms. The parasites most prevalent in resistant populations cultured were Cooperia spp. On 45/61 (74%) farms where Cooperia spp were present in suffi cient numbers, resistance to both ivermectin and albendazole was evident. No cases of levamisole-resistant Cooperia spp were detected. Resistance of Ostertagia spp to ivermectin was evident on 4/45 (9%) farms, to albendazole on 15/46 (35%) farms, and to levamisole on 4/46 (9%) farms. CONCLUSION: Anthelmintic resistance in parasitic nematodes of cattle is common in the North Island of New Zealand. Beef farmers need to be aware of the risks posed by anthelmintic resistance, and routine FECR testing is recommended to ensure optimal productivity and to guide decision-making when purchasing anthelmintics to be used on-farm.

Prevalence of anthelmintic resistance on sheep farms in New Zealand

Abstract AIM: To establish the prevalence of anthelmintic resistance in parasitic nematodes on sheep farms in New Zealand. METHODS: A cross-sectional prevalence study was conducted, using a standardised faecal nematode egg count (FEC) reduction (FECR) test (FECRT) for ivermectin, at a full (0.2 mg/kg) and half (0.1 mg/kg) dose rate, and albendazole, levamisole and albendazole-levamisole in combination, on 60 lambs (n=10 per group) on farms selected from throughout New Zealand. Farms that conformed with selection criteria were chosen at random (n=80) or with a history of suspected resistance to macrocy- clic lactone (ML) anthelmintics (n=32). Resistance to an an- thelmintic was inferred when there was <95% reduction in FEC 7-10 days after treatment. Larval cultures were performed for all control groups and for treated groups for which resistance was evident. RESULTS: Of the farms randomly selected, 36% showed ≥95% FECR for all anthelmintics tested; resistance to ivermectin at 0.1 and 0.2 mg/kg liveweight was evident on 36% and 25% of these farms, respectively. Resistance to both ivermectin (0.2 mg/kg) and levamisole was evident on 8/80 (10%) farms, to ivermectin and albendazole on 10/80 (13%) farms, and to iver- mectin, levamisole and albendazole on 6/80 (8%) farms. The prevalence of resistance to a half dose of ivermectin tended to be more prevalent on farms with a history of suspected ML resistance (p=0.06). Resistance to albendazole was seen across all the main parasite genera, and to levamisole in Nematodirus, Ostertagia (= Teladorsagia) and Trichostrongylus species. Resistance to ivermectin was dominated by Ostertagia spp, although Cooperia, Nematodirus and Trichostrongylus species were also implicated. CONCLUSION: Anthelmintic resistance in parasitic nema-todes of sheep is common in New Zealand. Not only was resistance to albendazole and levamisole common, but resistance to the ML, ivermectin, was at a higher prevalence than expected. Sheep farmers and advisors in New Zealand need to re-evaluate the way they manage parasites, and more research is urgently needed if the steady decline in anthelmintic susceptibility is to be halted.

Management of gastrointestinal nematode parasites on sheep farms in New Zealand

Abstract AIM: To report current farmer opinions and farming practices relating to control of gastrointestinal nematodes and anthelmintic resistance on sheep farms in New Zealand. METHODS: An interview-based cross-sectional study of grazing management and anthelmintic useage was conducted by veterinarians on 80 randomly selected sheep farms in New Zealand. RESULTS: Useable data were returned by 74/80 (92%) farmers who participated in the study. However, despite contacting 400 farmers the target sample size of 100 farms was not reached. The results indicated that only 31% of farms had previously tested for drench resistance, that effective quarantine-drenching of imported stock was not always carried out, and that farmers were more likely to integrate cattle than ewes into their grazing management of lambs. Furthermore, the number of drenches given to lambs had changed little in 25 years. The use of faecal egg counting by farmers has increased. CONCLUSIONS: Dependence on anthelmintics continues to be high on sheep farms in New Zealand. Whilst the number of drench treatments has changed little, there is more widespread use of persistent or long-acting treatments. Farmers need to be encouraged to monitor the resistance status of nematode populations on their farms and use this information to develop strategies aimed at maintaining susceptible alleles within the parasite populations and conserving the efficacy of existing drug families.

Farm management practices associated with macrocyclic lactone resistance on sheep farms in New Zealand

Abstract AIM: To identify farm practices associated with the presence of resistance to a macrocyclic lactone (ML) anthelmintic on sheep farms in New Zealand. METHODS: A cross-sectional study was conducted to test for associations between the presence of resistance to an ML anthelmintic (ivermectin) and management practices on sheep farms in New Zealand. Selection of farms was both random (n=80) and purposive (n=32; being farms with a history of suspected ML resistance). Resistance was inferred from faecal nematode egg count (FEC) reduction (FECR) tests (FECRTs) when there was <95% reduction in FEC 7–10 days after treatment with a half dose of ivermectin (0.1 mg/kg). A logistic regression model was built to identify farm-level factors that were associated with the presence or absence of ML resistance. RESULTS: Of the 112 flock managers that were approached for interview, 103 (92%) returned useable questionnaires. The odds of ML resistance were increased: on farms that had used long-acting ML products in ewes as a pre-lambing treatment for ≥3 of the previous 5 years (odds ratio (OR) = 7.2; 95% confidence interval (CI) = 1.7–30.3); on farms where <70% of the total stock units mid-winter were from sheep (OR=6.5; 95% CI=1.6–25.6); on farms which over the year purchased ≥10% of the number of sheep present mid-winter (OR=7.1; 95% CI=1.5–34.7); and on farms where the average wool diameter of the main flock was <37 (OR=4.1; 95% CI=1.1–14.7) microns. The model provided a good fit to the data (pseudo R2=0.64; Hosmer-Lemeshow statistic = 0.38). CONCLUSIONS: Explanatory factors identified as associated with the presence of ML (ivermectin) resistance on farms included the use of long-acting anthelmintic formulations in ewes pre-lambing, sources of refugia of unselected parasites on the farm, breed of sheep and their requirements for anthelmintic treatments, and the importing of resistant parasites with purchased stock. The study provides support for controls that aim to provide refugia of susceptible worms and that minimise the risk of introduction of resistance through effective quarantine-drenching.

Assessment of the duration of the pain response associated with lameness in dairy cows, and the influence of treatment

Abstract AIM: To assess the welfare impact of lameness on dairy cattle in New Zealand by measuring the duration of allodynia (decreased nociceptive threshold) and increased locomotion score, and to evaluate the influence of treatment on that duration. METHODS: After lame cows were treated using corrective paring by a veterinarian, they were allocated to one of six treatment groups. If the veterinarian determined that additional elevation of the lesion was not required the cow was randomly allocated to receive one of four treatments, viz 2 mg/kg tolfenamic acid, a plastic shoe to elevate the lesion, both treatments, or no further treatment. Cows that required additional elevation were treated using a plastic shoe and then randomly allocated to two separate treatment groups, either 2 mg/kg tolfenamic acid or no further treatment. Assessments of locomotion score (based on posture and gait) and mechanical nociceptive threshold (using a pneumatically actuated blunt pin) were made prior to treatment, and 3, 8, 28 and 100 days later. RESULTS: Data were collected from 149 lame cows from nine dairy farms. There were significant improvements in mean locomotion score and nociceptive threshold in all treatment groups. At all time-points after treatment, locomotion score and nociceptive threshold were significantly improved when compared with the previous time-point. Thus, in these cows, the deleterious effects of lameness persisted for longer than 28 days, despite treatment, as the mean locomotion scores and nociceptive threshold on Day 100 were better than those on Day 28. No significant long-term benefit of using tolfenamic acid at the time of treatment was observed on either locomotion score or nociceptive threshold, nor was there any benefit in using a plastic shoe in cases where it had been determined that such treatment was not necessary. CONCLUSIONS: This study demonstrated that the welfare impact of lameness on dairy cattle in New Zealand is of long duration even when treated effectively. In contrast to previous studies, no significant long-term benefit of using non-steroidal anti-inflammatory drugs (NSAID) at the time of treatment was observed, probably because unlike those previous studies the nociceptive threshold improved in the cattle which did not receive an NSAID, perhaps because treated cattle were kept on pasture rather than housed. CLINICAL RELEVANCE: The long duration of increased allodynia after treatment demonstrates that prevention of lameness rather than therapeutic treatment is the key to reducing its impact on the welfare of dairy cows.

A descriptive analysis of the foot lesions identified during veterinary treatment for lameness on dairy farms in north Taranaki

Abstract AIM: To analyse the records made during routine veterinary treatment of lame cows, to identify the types of lesions causing lameness of dairy cows in north Taranaki, their relative prevalence and distribution, and some of the cow-associated factors which affect these parameters. METHODS: Data concerning cow age and breed, lesion type, lesion site, and whether the examination was a revisit were collected from records of veterinary visits between December 1995 and July 2007. Data were analysed on a single- or two-factor basis, using χ and, where suitable, calculation of OR. RESULTS: The total number of individual cow treatments recorded was 4,488. The most commonly recorded lesion was white-line disease (WLD) (42% of diagnoses at first examination), and the second was sole injury (29%). Heifers accounted for 19% of cases, similar to the expected replacement rate. Jerseys accounted for 18% of cases, lower than the proportion of purebred Jerseys in the region (27%). There was a significant effect of age and breed on the prevalence and distribution of lesions. There were also significant differences between lesion types in their location, which were also influenced by breed and age. CONCLUSIONS: This study provided a comprehensive overview of the lesions causing lameness in dairy cattle in north Taranaki, and identified some of the factors which influence the development of lesions. More research is needed to better establish the aetiology and pathogenesis of lameness in cattle under New Zealand conditions. CLINICAL RELEVANCE: This study provides baseline data with which veterinarians can compare their results to identify significant patterns on specific farms, which will suggest specific causal factors for lameness on those farms and thus better guide prevention programmes.

The assessment of blood copper status in cattle: A comparison of measurements of caeruloplasmin and elemental copper in serum and plasma

Abstract AIM: To evaluate the effect of test, either copper (Cu) concentration or caeruloplasmin (CP) activity, and sample type, either serum or plasma, on the diagnosis of blood Cu status in cattle. METHODS: Paired serum and heparinised plasma samples taken from 125 cattle in 13 herds were tested for Cu concentration and CP activity. The individual results for serum Cu concentration and serum and plasma CP activities were compared with the plasma Cu concentration results, as were their diagnostic values as determined by reference ranges, i.e. ‘marginal’, ‘adequate’, ‘excess’. RESULTS: The overall mean serum Cu concentration was 2.92 µmol/L lower than the mean plasma Cu concentration; however, there was significant variability between individual samples, and the 95% limits of agreement ranged from 0.44 µmol/L more to 6.28 µmol/L less. The relationship between CP activity and plasma Cu concentration was less variable; the 95% prediction interval for plasma Cu concentration from CP activity was ± 2.8 µmol/L, and was unaffected by whether CP activity was measured in plasma or serum. Using the threshold currently recommended for ‘marginal’ status of <8.0 µmol/L for serum Cu concentration identified a significantly different population of cattle than a threshold of <9.0 µmol/L for plasma samples. Altering the threshold to <7.0 µmol/L for serum Cu concentration produced better agreement. For CP activity, a threshold of 15 IU/L for both serum and plasma identified the same population as a threshold of <9 µmol/L for plasma Cu concentration. CONCLUSIONS: Serum Cu concentration is not a suitable substitute for plasma Cu concentration for the detection of ‘marginal’ blood Cu status in cattle as the individual variability in the apparent loss of Cu during clotting is too great. In this study, CP activity, in both serum and plasma, was found to be a suitable substitute for the detection of ‘marginal’ blood Cu status. CLINICAL RELEVANCE: The use of serum Cu concentration rather than plasma Cu concentration in the diagnosis of Curesponsive disease in cattle needs to be re-evaluated as does the way in which individual sample results are used in such tests.

Epidemiology of the epidemic of bovine anaemia associated with Theileria orientalis (Ikeda) between August 2012 and March 2014.

Abstract AIMS: To describe the epidemiology of the epidemic of bovine anaemia associated with Theileria orientalis infection (TABA) in New Zealand between 30 August 2012 and 4 March 2014. METHODS: Blood samples and associated data were obtained from cases of TABA. The case definition for TABA was met when piroplasms were present on blood smears and the haematocrit was ≤0.24 L/L. Samples were analysed using quantitative PCR (qPCR) assays for the detection of T. orientalis Ikeda type. Only cases that were positive in the qPCR assays were included in the analysis. A case herd was defined as a herd that had ≥1 animal positive for T. orientalis Ikeda. Movement records for farms were accessed through the national animal identification and tracing scheme. The OR for cattle movements onto a case farm compared to a non-case farm was estimated using a generalised estimating equation model and the geodesic distance for movements onto case and non-case farms compared using Students t-test. The kernel-smoothed risk of disease at the farm level was calculated using an extraction map and the clustering of diseased farms in time and space was measured using the spatial temporal inhomogeneous pair correlation function. RESULTS: In the first 18 months there were 496 case herds; 392 (79%) were dairy and 104 (21%) beef herds. Of 882 individual cases, 820 (93.0%) were positive for T. orientalis Ikeda in the qPCR assays. Case herds were initially clustered in the Northland, then the Waikato regions. The OR for a case farm compared to a non-case farm having ≥1 inward cattle movements was 2.03 (95% CI=1.52–2.71) and the distance moved was 26 (95% CI=20.8–31.3) km greater for case farms. The risk of disease was highest in a north, north-eastern to south, south-western belt across the Waikato region. The spatial-temporal analysis showed significant clustering of infected herds within 20–30 days and up to 15 km distant from a case farm. CONCLUSIONS: Theileria orientalis Ikeda type is likely to have been introduced into regions populated with naïve cattle by the movement of parasitaemic cattle from affected areas. Local spread through dispersed ticks then probably became more important for disease transmission between herds once the disease established in a new area. CLINICAL RELEVANCE: Dairy and beef farming in the North Island of New Zealand will be significantly changed in the coming years by the incursion of this new disease.

Prevalence of Streptococcus dysgalactiae subsp. equisimilis and S. equi subsp. zooepidemicus in a sample of healthy dogs, cats and horses

AIMS: To estimate the prevalence of β-haemolytic Lancefield group C streptococci in healthy dogs, cats and horses; to determine if frequent contact with horses was associated with isolation of these species from dogs and cats; and to characterise recovered S. equi subsp. zooepidemicus isolates by multilocus sequence typing. METHODS: Oropharyngeal swabs were collected from 197 dogs and 72 cats, and nasopharyngeal swabs from 93 horses. Sampling was carried out at the Massey University Veterinary Teaching Hospital, on sheep and beef farms or on premises where horses were present. All animals were healthy and were categorised as Urban dogs and cats (minimal contact with horses or farm livestock), Farm dogs (minimal contact with horses) and Stable dogs and cats (frequent contact with horses). Swabs were cultured for β-haemolytic Streptococcus spp. and Lancefield group C streptococcal subspecies were confirmed by phenotypic and molecular techniques. RESULTS: Of the 197 dogs sampled, 21 (10.7 (95% CI= 4.0–25.4)%) tested positive for S. dysgalactiae subsp. equisimilis and 4 (2.0 (95% CI=0.7–5.5)%) tested positive for S. equi subsp. zooepidemicus. All these isolates, except for one S. dysgalactiae subsp. equisimilis isolate in an Urban dog, were from Stable dogs. S. dysgalactiae subsp. equisimilis was isolated from one Stable cat. Of the 93 horses, 22 (23.7 (95% CI=12.3–40.6)%) and 6 (6.5 (95% CI=2.8–14.1)%) had confirmed S. dysgalactiae subsp. equisimilis and S. equi subsp. zooepidemicus isolation respectively. Isolation of S. dysgalactiae subsp. equisimilis from dogs was associated with frequent contact with horses (OR=9.8 (95% CI=2.6–72.8)). Three different multilocus sequence type profiles of S. equi subsp. zooepidemicus that have not been previously reported in dogs were recovered. CONCLUSIONS AND CLINICAL RELEVANCE: Subclinical infection or colonisation by S. equi subsp. zooepidemicus and S. dysgalactiae subsp. equisimilis occurs in dogs and further research on inter-species transmission and the pathogenic potential of these Lancefield group C streptococci is needed. Complete speciation of β-haemolytic streptococci should be recommended in clinical cases and the possible exposure to horses and their environment should be considered in epidemiological investigations.

Efficacy of blanket treatment of cows and heifers with an internal teat sealant in reducing the risk of mastitis in dairy cattle calving on pasture

Abstract AIM: To evaluate the benefit of blanket treatment of all milking cows at drying-off and all replacement heifers one month prior to the planned start of mating with an internal teat sealant on the incidence of mastitis, and somatic cell counts (SCC), postpartum in a 650-cow herd with a mastitis incidence in early lactation of 15% in cows and 26% in heifers. METHODS: Prior to drying-off, lactating cattle were divided on the basis of SCC and mastitis history. Cattle with records of individual SCC >150,000 cells/ml or mastitis in the previous lactation were treated with a cloxacillin-based dry-cow therapy (DCT), while the remaining cattle received no antibiotics. Cattle in each of the two groups were then randomly assigned to receive either an internal teat sealant or no further treatment. Additionally, one month prior to the planned start of calving the rising 2-year-old heifers were also randomly assigned to receive either an internal teat sealant or no treatment. All clinical mastitis cases were recorded for the first 10 weeks after the start of calving, while SCC were measured on three occasions during the subsequent lactation. RESULTS: Data were available from 466 cows and 206 heifers; treatment with the internal teat sealant significantly reduced the incidence of mastitis in both groups. For cows, the reduced risk of mastitis due to treatment with the teat sealant was not significantly different between cows, which, based on their mastitis history, required dry-cow antibiotics and those which did not. There was no effect of teat sealant on the mean SCC of any group at any time-point. CONCLUSIONS: On this farm, treatment of all cows and heifers prior to parturition with an internal teat sealant significantly reduced the risk of clinical mastitis. The benefits of an internal teat sealant were the same when used in combination with antibiotics in cows with a history of mastitis as when used alone in cows with no such history. CLINICAL RELEVANCE: These data support the proposition that blanket treatment with an internal teat sealant of all cows due to enter the milking herd can be a useful method of mastitis control. They also suggest that combined therapy with dry-cow antibiotics and internal teat sealants can be beneficial under New Zealand conditions. More detailed research on more farms in more areas of New Zealand is required to confirm these suggestions.